InvestorsHub Logo
Followers 0
Posts 109
Boards Moderated 0
Alias Born 04/06/2020

Re: None

Tuesday, 03/19/2024 9:26:33 AM

Tuesday, March 19, 2024 9:26:33 AM

Post# of 36558
News: Revive Therapeutics To Submit Type C Meeting Request with FDA for Bucillamine to Treat Long COVID

March 19, 2024

https://www.globenewswire.com/en/news-release/2024/03/19/2848420/0/en/Revive-Therapeutics-To-Submit-Type-C-Meeting-Request-with-FDA-for-Bucillamine-to-Treat-Long-COVID.html